PRIMARY MALIGNANT LYMPHOMA OF THE BREAST A Case Report and Review of the Japanese Literature by Tsunoda Tsukasa et al.
Acta Med. Nagasaki 35:137-141
PRIMARY MALIGNANT LYMPHOMA OF THE BREAST 
 A Case Report and Review of the Japanese Literature
  Tsukasa TSUNODA 1, Junichirou FURUI, Harunobu MAEDA 
Nobuo MOCHINAGA, Tsutomu TOMIOKA, Shigetoshi MATSUO 
 Toshifumi ETO, Ryoichi TSUCHIYA, Kensuke YAMAMOTO 2
1 Second Department of Surgery, Nagasaki University School of Medicine, Nagasaki, Japan 
         2 Hagi Gastrointestinal Hospital, Hagi City, Yamaguchi, Japan
Received for Publication, June 25, 1990
SUMMARY : A 26-year-old pregnant woman was admitted to Nagasaki University 
Hospital complaining rapid enlargement of masses in the bilateral breasts and the right 
axilla. Biopsy of the right breast revealed malignant lymphoma. Simple mastectomy 
plus axillary node dissection on the right side (Br+Ax) and excision of the tumor in the 
left breast were performed. Histologically, the tumor was a diffuse lymphoma of the 
medium-size cell type according to the LSG classification, originated from B cells. After 
operation, Vincristine, Adriamycin, and Cyclophosphamide were administrered, but 
chemotherapy was terminated because of marked leukopenia. The patient has remained 
asymptomatic for 7 years without any treatment, and there is no evidence of recurrence. 
 We have collected 79 cases of malignant lymphoma of the breast reported in the Japanese 
literature, including the present case, and examined factors that might affect the prognosis 
of patients. However, age, size of tumor, axillary lymph node involvement, histological 
findings, and type of therapy did not exert a significant influence. The most critical 
factor in a poor prognosis was the extramammary involvement of malignant lymphoma.
       INTRODUCTION 
 Primary malignant lymphoma of the breast 
is rare. Among 25, 927 cases of histologically 
verified breast cancer collected for the 36th 
meeting of the Japan Mammary Cancer Society, 
only 45 cases (0.17%) were malignant lym-
phomas'). We have experienced a case of the 
disease in pregnancy. We report the case and 
discuss the prognosis of 79 cases collected from 
the Japanese literature.
        CASE REPORT 
 A 26-year-old pregnant Japanese woman 
noticed a small 3 cm mass in the right breast
in the autumn of 1982. The mass enlarged 
progressively. Another small mass appeared in 
the left breast. She visited a hospital in Italy, 
where a biopsy was taken from the right breast. 
A diagnosis of malignant limphoma was made. 
She returned to Japan and was admitted to 
Nagasaki University Hospital on October 13, 
1982, complaining rapid enlargement of the right 
breast. There was no pain or discharge from 
the nipple. She was in the 35th week of 
pregnancy. The family and past histories were 
unremarkable. 
 On physical examination, the height was 164 
cm and the body weight 63kg. Anemia was 
present. The right breast was almost completely 
occupied by a solid tumor, measuring 20 X 17cm 
(Fig. 1). There was fixation of the mass to the
Fig. 1. A photograph of the right breast, showing a 
      20 x 17 cm solid tumor with the reddish and 
      ulcerated overlying skin.
Fig. 2. The cut surface of the right resected breast 
       tumor, which is nodular, solid, well-defined, 
      yellowish-white, and partially hemorrhagic.
Fig. 3. The tumor is composed of diffusely infil-
      trated pleomorphic medium-sized lympho-
      blastic cells with large nuclei and scant 
      cytoplasm. (H&E x 400)
overlying skin but no retraction of the nipple. 
The overlying skin was reddish and ulcerated.
On the left side, a solid tumor, measuring 7.5X 
5cm, occupied the upper half of the breast. The 
tumors in both the right and left breasts were 
firm, elastic, nodular, and freely movable from 
the chest wall. In the right axilla, there was 
a firm, elastic, nontender, and movable lymph 
node measuring 7cm in diameter. No enlarged 
nodes were palpable in other sites. Hepato-
splenomegaly was not apparent in the abdomen. 
 Examination of the blood showed a 
hemoglobin level of 9.5g and a white cell count 
of 7100/mm3 with normal differential cell count. 
The blood chemistry findings were within 
normal limits except for 1322mu/ml of LDH 
(normal : 146-382). Computed tomography of the 
chest and abdomen revealed neither hepato-
splenomegaly nor enlarged nodes. 
 A right simple mastectomy, right axillary node 
dissection and excision of the tumor in the left 
 breast were carried out on October 15, 1982, 
just after a Caesarean section. 
 The cut surface of the tumor in the right 
breast was nodular, solid, well-defined, yel-
lowish-white, and partially hemorrhagic. 
Microscopically, the tumor was composed of 
diffusely infiltrated pleomorphic medium-sized 
lymphoblastic cells with large nuclei and scant 
cytoplasm. The disease was diagnosed as 
diffuse lymphoma of the medium-sized cell type 
according to the classification of the 
Leukemia-Lymphoma Study Group (LSG), and 
B cell originated. 
 After operation, a total dose of 4mg of 
Vincristine, 240mg of Adriamycin and 4800mg 
of Cyclophosphamide were administered from 
August 16 to November 10. Chemotherapy was 
terminated due to the development of marked 
leukopenia. The wound healed without incident. 
The white blood cell count returned to 2400/ 
mm3 on November 29. The patient has remained 
asymptomatic for 7 years without any treatment, 
and there is no evidence of reciirrPnce
        DISCUSSION 
 It is known that the breast contains periductal 
and intralobular lymphoid tissues2. These 
tissues occasionally contain germinal centers 
that may be the site of origin of malignant 
lymphoma3). In our case, microscopic studies
Table 1. Reported cases of malignant lymphoma of the breast in Japan
No Author Year Age Sex Site Size Ax.Lym. Histological Therapy Subsequent Prognosis                                 (cm) I
nvol findings Operation Radi. Chemo. Involvement 
1 Horiguchi '50 20 F B Ret.cell sar. General 
2 Hara '53 29 F B Ret.cell sar. General 
3 Tsuchiya '58 20 F R Ret.cell sar. Radical + + Lung,Skin Died 8mos. 
4 Sakurai '62 27 F R Fist Ret.cell sar. Radical + Liv. 2mos. 
5 Asai '63 16 F B 7X4 Ret.cell sar. General Died 4days 
6 Fujimori '64 64 F R Thumb tip - Ret.cell sar. Radical Liv. 7.8yrs. 
7 Shimura '64 37 F L Bean - Ret.cell sar. Radical + Liv. 2.5yrs. 
8 Watanabe '64 47 F R Pigeon egg - Ret.cell sar. Radical + Liv. 1.5yrs. 
9 Kondou '65 58 F R Walnut - Ret.cell sar. Radical Liv. 10mos. 
10 Inui '65 46 F L Hen egg + Ret.cell sar. Radical + Mediastinum Died 4mos. 
11 Satou '66 50 F L 4.5 X 4.5 - Ret.cell sar. Radical + + General Died 5days 
12 Noda '66 37 F R Ret.cell sar. Radical + + Leukemic Died lOmos. 
13 Noda '66 47 F R Lymph.sar. Radical + Leukemic Died 4mos. 
14 Yoshida '70 16 F L 6X5 + Ret.cell sar. Radical + + Lung,Skin Died 5mos. 
15 Yoshida '70 48 F R 18 X 15 - Ret.cell sar. Radical Ret.peri. Died 7mos. 
16 Nakagawa '70 44 F L 2.5 X 2.5 - Lymph.sar. Radical + Died 3mos. 
17 Nakagawa '70 32 F R 10 X 9 + Lymph.sar. Radical + Died 6mos. 
18 Miura '70 19 F L 4.6 X 4.2 Ret.cell sar. Excision Liv. 34mos. 
19 Miura '70 25 F B 6.4 X 5.0 - Ret.cell sar. Radical + General Died l lmos. 
20 Tanaka '70 52 F R Fist + Lymph.sar. Radical + Died 3yrs. 
21 Nishizawa '70 37 F R 8X8 + Ret.cell sar. Radical + Leukemic Died 8mos. 
22 Kinoshita '70 46 F L Hen egg + Ret.cell sar. Radical + Mediastinum 
23 Nakashima '70 50 F L 3X4 Ret.cell sar. 
24 Nakamura '71 48 F L Goose egg + Ret.cell sar. Radical + Liv. 2mos. 
25 Yoshitani '72 60 F R 1X1 + Ret.cell sar. Radical Liv. 1.3yrs. 
26 Otowa '73 33 F B Hen egg + Ret.cell sar. Radical + + Small intes. Died 4mos. 
27 Watanabe '74 27 F R 2.5 X 2.5 - Lymph. sar. Radical General Died lOmos. 
28 Watanabe '74 32 F R 10X8 + Ret.cell sar. Radical + Rt.Neck Died 2mos. 
29 Watanabe '74 32 F R 2.5X2.5 + Ret.cell sar. Excision + Liv. 2.8yrs. 
30 Shiromatsu '74 13 F L 9X9 - Ret.cell sar. Radical + Liv. 4mos. 
31 Akao '75 25 F R 6X5 - Ret.cell sar. Radical + Liv. 3.6yrs. 
32 Oomuro '75 32 F L 4.5 X 3 - Ret.cell sar. Radical + + Liv. l lmos. 
33 Mura '76 58 F L 3.5 X 3 - Ret.cell sar. Radical + Liv. 16mos. 
34 Tanaka '77 24 F R 1.0 - Ret.cell sar. Br + Died 2yrs. 
35 Tanaka '77 66 F L 5.8 X 5.2 - Ret.cell sar. Br + General Died 6mos. 
36 Tanaka '77 38 F R 1.5 - Ret.cell sar. Radical + Liv. 10.5yrs. 
37 Tanaka '77 67 F R 2.4 X 1.4 - Ret.cell sar. Radical + General Died 5mos. 
38 Tanaka '77 56 F L 3.0 + Lymph.sar. Br + + Heart,Spleen Died 4mos. 
39 Tanaka '77 83 F R 2.5 X 2.0 - Ret.cell sar. + Died 14mos. 
40 Tanaka '77 79 F R 1.5 - Ret.cell sar. Br Liv. 15mos. 
41 Marutani '77 53 F R 4 X 3 - Ret.cell sar. Radical + + Liv. 2yrs. 
42 Kawage '77 25 F R 14 X 13 + Ret.cell sar. Radical + Brain Died 2mos. 
43 Yamaguchi '79 74 F L First - Ret.cell sar. Radical + + Liv. 3yrs. 
44 Ikeda '79 32 F L 13.5 X 12 Ret.cell sar. Excision + Brain Died 2.7yrs. 
45 Satou '79 64 F R 12 X 11 + Ret.cell sar. Radical + Liv. lyrs. 
46 Kosaka '79 52 F L 3X3 - Lymph.sar Radical + Liv. 5mos. 
47 Oohashi '80 56 F L 3.5 X 3 - Ret.cell sar. Radical + + Liv. 3.3yrs. 
48 Seto '81 45 F R 21.5 X 20 + Ret.cell sar. Radical + + Died 102days. 
49 Kouno '81 49 F B 12 X 9 + Lymph.sar + Died 15mos. 
50 Yamashita '82 54 F R 4 + Radical + + Liv. 7mos. 
51 Komaki '83 14 F R 6.5 X 5.5 + Diffuse,Small + + General Died l0mos. 
52 Nakamura '83 38 F R Hen egg - Folli.,Medium Radical + Leukemic Died 8mos. 
53 Koyama '83 72 F B 5.5 X 3.5 - + Died 
54 Kawamura '83 14 F B 14 X 13 - Lymph.sar. 
55 Suzuki '83 72 F R Ret.cell sar. Radical + Liv.6. 8yrs. 
56 Keshigawa '84 65 F R Ret.cell sar. Radical + Died 69days 
57 Yamamoto '84 49 F R 4X4 + Diffuse,Large Radical + Liv. 6mos. 
58 Kawaba '85 62 F L 4.5 + Diffuse,Medium Br+Ax +
59 Tanada '85 51 F L 3.5x2.5 - Diffuse,Large Radical + General Died 4mos. 
60 Hori '85 67 F L Ret.cell sar. Radical + Liv. 7mos. 
61 Sou '85 57 F R 5.5 x 5 - Iiffuse,Small Radical + + General Died lyr. 
62 Sai '85 81 M R 4X4 - Lymph.sar. Br Liv. 4mos. 
63 Yamakawa '86 14 F R 6.5 x 5.5 + Diffuse,Small + + Liver,Bone Died 9mos. 
64 Yamakawa '86 45 F L 5.5 x 3.5 - Diffuse,Large Radical + + Brain Died 9mos. 
65 Yamakawa '86 58 F L + Diffuse,Large + Liv.l7mos. 
66 Yamakawa '86 50 F R 3.3 x 2.5 - Diffuse,Large Radical + Liv. l4mos. 
67 Yamakawa '86 62 F R 3.7 x 2.8 - Diffuse,Large Radical + Liv. 9mos. 
68 Biwata '86 74 F B 5.6 x 2.7 + Diffuse,Small Radical + Liv. 1.7yrs. 
69 Hirata '86 74 F R 5.5 x 5 Diffuse,Medium Radical + 
70 Masuda '86 65 F R 3.5 x 4 - Diffuse,Medium Radical + Liv. limos. 
71 Saitou '86 68 F R 10.5 x 9.5 + Radical + 
72 Takahashi '87 23 F R 5.5 x 5 Diffuse,Mixed Br+Ax + Liv. 3yrs. 
73 Goushi '87 48 F L 3x3 + Diffuse,Medium + Liv. lyrs. 
74 Kawaguchi '88 78 F L 8X4 - Diffuse,Large Br+Ax + + Leukemic Died 205days 
75 Yamoto '88 20 F L 6X4 - Folli.,Medium + Leukemic Died 14mos. 
76 Komatsu '88 65 F L 4 x 3.5 - Diffuse,Midium Br+Ax + Liv. 110days 
77 Katsuki '89 34 F R 6.5 x 5.5 + Diffuse,Mixed Radical + + General Died l lmos. 
78 Nakano '89 34 F B Burkit's Lym. Br+Ax+Sc + + Brain Died 20mos. 
79 our case '90 26 F B 20X 17 + Diffuse,Medium Br+Ax,Exc + Liv. 7yrs.
Site (B=Bilateral, R=Right, L=Left), Ax. Lym. Invol.=Axillary lymph node involvement Classification of 
common use (Ret. cell sar.=Reticulum cell sarcoma, Lymph. sar.=Lymphosarcoma), LSG's classification 
(Diffuse=Diffuse lymphoma, Folli.=Follicular lymphoma, Small=Small cell type, Medium=Medium sized cell 
type, Mixed=Mixed type, Large=Large cell type), Radi.=Radiation therapy, Chemo.=Chemotherapy, Ret. 
peri.=Retroperitoneum, Small intes.=Small intestine Liv.=Living
revealed diffuse lymphoma of the medium-sized 
cell type. The lymphomatous infiltrates were 
closely associated with the mammary tissues. 
Except for a right axillary lymphnode, no extra-
mammary involvement was found clinically. 
From the above findings, our case can be 
accepted as primary malignanat lymphoma of 
the breast according to Wiseman's criteria'). 
 We collected and analyzed 79 cases of 
malignant lymphoma of the breast, among 
which 78 had been reported in the Japanese 
literature between 1950 and 1989, including our 
own case. A summary of these cases is 
presented in Table 1. Ages ranged from 13 to 
83 years with a mean age of 45.9 years. Only 
one male suffered from this disease. Three 
cases were associated with pregnancy. Lym-
phoma, it is said, tends to involve the right 
breast5>. In our series, the initial involvement 
was right in 41 patients, left in 27, and bilateral 
in 11. The size of the tumor varied from a bean 
size to 20cm in diameter. Axillary lymph node 
involvement was found in 27 of the 63 cases 
(42.8%) for which lymph node findings had been 
recorded. Histologically, so-called reticulum cell 
sarcoma was the most common type in the past. 
By LSG's classification, diffuse lymphoma of the 
large cell type was common. Radical mas-
tectomy was performed in 57 cases. Twenty-six 
patients received supplementary radiotherapy, 
and adjuvant chemotherapy was employed in 
40 cases. 
 The clinical course was usually rapid and 
fatal. Oberman reported that 5 of 6 patients 
died within one yearn. Similarly, Wiseman 
reported that 10 of 16 patients died within 2 
years, and only 3 patients were alive after 5 
years. In our series, 34 patients died within two 
years, and i5 patients lived more than 2 years. 
 An investigation was conducted into what 
factors might have prognostic values. The 
patients were divided into 2 groups, namely, 
those who died within 2 years and those who 
survived 2 years or more, but no significant 
difference was observed in the age or the size 
of the tumor between the two groups. There 
was also no significant difference in axillary 
lymph node involvement between the two 
groups. DeCosse also reported that the presence 
or absence of axillary lymph node involvement 
did not seem to affect the prognosis and stated 
that the most important factor in prognosis was 
the histological type of malignant lymphoma'). 
In our series, however, there was no significant 
difference in the histological findings between 
the two groups. It has also been reported that
radical mastectomy combined with supplemen-
tary radiotherapy is useful in the treatment of 
primary malignant lymphoma of the breast8'9>. 
Again, however, the prognosis in our series was 
not significantly affected by the type of therapy. 
Only 4 patients lived longer than 5 years, and 
the longest survival was 10.5 years. 
 In a review of the long-term survivors, we were 
unable to find any influential factors for lengthy 
survival. However, the most critical factor in 
poor prognosis was considered to be the 
extramammary involvement of malignant 
lymphoma. 
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